Benjamin G Barwick

36PUBLICATIONS
175CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 22, 2026
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

|Sep 02, 2025
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.

Nikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen

|May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar

|Dec 18, 2024
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis.

Remya Nair, An H Vu, Abigail K Freer

|Jul 24, 2024
KDM6A regulates immune response genes in multiple myeloma.

Daphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick

|Apr 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome.

Amin Sobh, Elena Encinas, Alisha Patel

Pageof 6

Frequent Collaborators

19 joint publications

Lawrence H Boise

6 joint publications

Vikas A Gupta

6 joint publications

Craig C Hofmeister

5 joint publications

Jonathan J Keats